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SUMMARY
A rare case of thalassaemia-intermedia involving a non-
deletion alpha thalassemia point mutation in the α1-globin
gene CD59 (GGCGAC) and a deletion α+ (-α3.7) thalassaemia
in which use of  high performance liquid chromatography
(HPLC) C-gram  Hb subtype profile and  DNA molecular
analysis helped establish the diagnosis.
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INTRODUCTION
The α-thalassemias are the most common single-gene diseases
in the world.  They are characterized by a reduction or
complete absence of α-globin gene expression.  Normal
individuals have two α genes on each chromosome 16
(αα/αα).  The loss of one (-α) or both (--) of the cis-linked
genes are the most common causes for α-thalassaemias.
Patients with alpha-thalassaemia intermedia with only one
functional α-globin gene (--/-α) develop chronic haemolytic
anaemia of variable severity.  HbH disease is the common
cause alpha-thalassaemia intermedia.  This condition is
characterized by a strongly positive H-inclusion test. Non-
deletional HbH disease has been described to be more severe
than the deletional type1. The most severe form of alpha
thalassaemia is Hb Barts hydrops foetalis where there are no
functional α-globin genes (--/--) and results in the condition
where death occurs in utero or within a few hours of birth.  In
this case report, a rare case of alpha- thalassaemia intermedia
is presented where the H-inclusion test is negative.
CASE REPORT
A 52-year old Malay male presented with pallor, generalized
malaise, jaundice and hepatosplenomegaly. There was no
family history of thalassaemia.  The haematology work-up
included a full blood picture, thalassaemia screen tests and a
liver profile.  Blood specimens were drawn into tubes (Becton
Dickinson Vacutainer Systems) containing dipotassium
ethylene diamine tetraacetic acid (EDTA) for full blood
picture and thalassaemia diagnosis (quantification of Hb
subtypes and DNA studies), into plain tubes for serum
ferrritin and liver profile studies. 
Thalassaemia screen using the BHES protocol was done.  The
acronym BHES refers to a multi-step process for screening of
thalassaemia where B is for blood counts and blood film, H
for high performance liquid chromatography, E for
electrophoresis and S for stability. B: Blood counts were
generated on an automated blood counter (Cell-Dyn, Abott
laboratories).  He was noted to have severe anaemia with a
haemoglobin level of 5.6 gm/dl (normal range 13-18 gm/dl),
hypochromic-microcytic red cell indices, reticulocytosis and a
thalassaemia peripheral blood film (anisopoikilocytosis,
hypochromia, basophilic stippling, target cells, and
fragments).  H: a specimen collected in EDTA was analyzed on
the Bio-Rad Variant high performance liquid chromatography
(HPLC) Hb analyzer (Bio-Rad Laboratories) to determine the
distribution of Hb subtypes with the use of the β-thalassaemia
short program recorder pack as described in the instruction
manual for the assay.  The Hb subtypes noted were HbA, HbF,
HbA and a pre-run peak of Hb Barts, shown Figure 1. There
was no HbH seen.  E: Hb electrophoresis by automated
agarose gel electrophoresis (Sebia) on alkaline pH8.5 showed
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A=prerun peak of Hb Barts, RT=retention time in minutes
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Fig. 1: HPLC C-gram of alpha thalassaemia-intermedia (CD59/-α3.7)
similar findings of Hb subtypes seen with HPLC.  S: the H-
inclusion test was negative.  The serum ferritin was 340µg/L
(normal 150-300 µg/L). The liver enzymes were normal and
the unconjugated bilirubin level was raised. The antiglobulin
test (Coombs test) was negative. Genomic DNA was extracted
from peripheral blood using standard methods and multiplex
polymerase chain reaction (PCR)2 was  done to detect the
following ·-thalassaemia mutations: single gene deletion (-α3.7,
-α4.2) , two gene deletions (--SEA, --FIL, --MED, --THAI, --α20.5 and non-
deletion α-thalassaemia (initiation codon (CD) (ATGGTG),
CD30, CD35 (TCCCCC), Hb Quong Sze or CD125
(CTGCCG),  Hb Constant Spring or CD 142 (TAACAA)
and, CD59 (GGCGAC) 3. The patient was found to be
heterozygous for the single deletion (-α3.7) and the non-
deletion mutation CD59 (GGCGAC). 
DISCUSSION
Patients with alpha thalassaemia-intermedia have moderate
anaemia with Hb levels between 7-10gm/dl. The
manifestations include thalassaemia facies, jaundice and
hepatosplenogaly that range from mild to moderate.  Growth
and development is normal. Gallstones and iron overloading
in the absence of blood transfusions have been seen.  The H-
inclusion test is strongly positive in these cases.  In this case
report, the patient had α-thalassaemia intermedia phenotype
with severe anaemia (Hb 5.6 gm/dl) with thalassaemia
features in the peripheral blood film in the absence of a
positive H-inclusion test. 
Alpha-thalassaemia is caused by both deletion and non-
deletion mutations in the alpha globin gene complex. In
contrast to β-thalassaemia, deletions are more common than
non-deletional defects. Commonly, α-thalassaemia-
intermedia presents as HbH disease from the interaction of
deletion of both the α-globin genes in cis (α0) (αthal 1) and α+
(αthal 2) phenotype.  The molecular defects resulting in a
single deletion of the α globin gene are the rightward deletion
-α3.7 and the leftward deletion -α4.2 with -α3.7 being the more
common mutation.  The double deletion defects (α0) of the α
globin genes in cis are --SEA, --FIL, --MED, --THAI and --20.5.  The most
common non-deletion single gene defect (α+) is Hb Constant
Spring. This is a termination codon defect (TAACAA) results
in a long mRNA with 31 extra amino acids being formed. The
long mRNA is unstable resulting in reduced production of α
globin chains and a α+ phenotype.  HbH-Constant Spring has
a more severe clinical phenotype than deletion HbH disease.
The nondeletion molecular defect in the α-globin 1 gene
CD59 (GGCGAC) results in the formation of hyperunstable
α Hb variant.  It is a rare cause for α-thalassaemia-intermedia
when the mutation combines with a α+ deletion defect.  If the
mutation occurs in the α2-globin gene it results in hydrops
fetalis. mRNA formation in α2:α1 is 3:1 and accounts for the
condition being more severe when the α2 gene is involved.
The two cases first reported with α-thalassaemia-intermedia
were from Turkey4.  The true frequency of  the molecular
defect in the α-globin 1 gene CD59 (GGCGAC) is unknown
as the defect can only be ascertained by DNA studies.  This α
Hb variant is hyperunstable and has no product to be
visualized by routine haematology studies.  Screening for
thalassaemia by blood counts and Hb subtyping will miss the
diagnosis in contrast to beta-thalassaemia where
determination of Hb subtypes presumptively identifies the
presence of thalassaemia.
This is the first report described in a Malay patient from
Malaysia.  The presence of α1CD59 (GGCGAC) may be the
result of migration from countries bordering the
Mediterranean sea as the Malays have links with Turkey, Iran
and the Middle East.  The true frequency of this alpha Hb
variant cannot be identified by screening methods such as the
BHES protocol as it is hyper-unstable.  This case report
highlights the need to consider a hypersunstable α Hb variant
[CD59 (GGCGAC)]  in a patient with alpha thalassaemia-
intermedia  in the absence of a strongly positive H-inclusion
test with normal Hb subtypes and presence of Hb Barts.
Confirmation is required by DNA analysis as shown in this
case.
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